Intuitive Surgical (ISRG) Stock

$588.81 0.31 (0.05%)
Market Cap: $210.00B | NASDAQ

Intuitive Surgical Chart


Company Profile

Price: $588.81

Market Cap: $210.00B

Exchange: NASDAQ

CEO: Dr. Gary S. Guthart Ph.D.

Sector: Healthcare

Industry: Medical - Instruments & Supplies

Employees: 13.68K

Headquarters: Sunnyvale, CA

Business Summary

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Intuitive Surgical News

If You'd Invested $10,000 in Intuitive Surgical Stock 10 Years Ago, Here's How Much You'd Have Today

Many of us occasionally look at an impressive stock that we don't own and wonder, "How much would I have today if I'd invested in it some years ago?" One company that those in the know might wonder about is Intuitive Surgical (ISRG -0.15%) -- a giant in the robotic surgery arena.

News image

Intuitive Surgical Just Posted a Solid Quarter, but This Is Why the Stock Could Be in Trouble This Year

Intuitive Surgical (ISRG 1.94%) should arguably be doing a whole lot better after coming off the release of some strong earnings numbers. Business is doing well, the growth rate is solid, and in the long run, the company has a lot of potential.

News image

2 Monster Stocks to Buy and Hold Forever

It's hard to predict which way the market, or any specific company, will move in a short period, like a single year. But the longer we expand our horizon, the more likely it is that excellent companies, and equities in general, will deliver solid returns.

News image

Top Wall Street analysts are optimistic about the growth prospects of these 3 stocks

TipRanks' analyst ranking service highlights three stocks favored by Wall Street, including Netflix and Intuitive Surgical.

News image

Is Intuitive Surgical Stock a Buy?

Intuitive Surgical (ISRG 1.30%) capped off a record-breaking 2024 with a blowout fourth-quarter earnings report. For the period ended Dec. 31, the medical technologies (medtech) giant delivered adjusted earnings per share (EPS) of $2.21, well above the $1.79 consensus Wall Street estimate.

News image

Up 950% Over the Past Decade, This Hot Stock Just Saw Its Revenue Soar. Is It Still a Buy?

Over the past decade, Intuitive Surgical (ISRG -0.58%) has proven to be a long-term winner in the healthcare sector. The stock is up more than 950% in that time frame, and more than 60% over the past year.

News image

Is ISRG a Buy After Logging Robust System Placements in Q4?

Intuitive Surgical has maintained an uptrend so far this year on the back of robust da Vinci portfolio performance. The stock has also gained during the past month.

News image

Buy, Sell, Or Hold ISRG Stock At $585?

Intuitive Surgical (NASDAQ: ISRG) recently reported its Q4 results, with revenues and earnings exceeding the street estimates. The company reported revenue of $2.4 billion and adjusted earnings of $2.21 per share, compared to the consensus estimates of $2.2 billion and $1.79, respectively.

News image

Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

News image

Intuitive Announces $45 Million Donation to the Intuitive Foundation to Promote Health and Advance Education

SUNNYVALE, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced a $45 million gift to the Intuitive Foundation that will be used to support the Foundation's mission of reducing the global burden of disease and suffering through philanthropy, research, and education aimed at better outcomes for patients everywhere.

News image

Prediction: This Company Will Have a Trillion-Dollar Market Cap by 2040

The list of companies with market caps of $1 trillion or more remains extremely short. However, there's little doubt that more companies will join this elite group over the coming decades.

News image

Intuitive Surgical Drops After Earnings Beat. Wall Street Is Still Optimistic.

The company reported a fourth-quarter earnings and sales beat, but guidance left much to be desired.

News image

Why Intuitive Surgical Stock Was Pulling Back Today

Shares of Intuitive Surgical (ISRG -3.67%) were pulling back today as a strong fourth-quarter earnings report didn't seem to be enough to justify the medical device maker's lofty valuation. Its guidance for 2025 was also slightly below estimates, which can often trigger a sell-off for growth stocks.

News image

These Analysts Boost Their Forecasts On Intuitive Surgical Following Strong Q4 Results

Intuitive Surgical Inc ISRG reported better-than-expected financial results for the fourth quarter after the market close on Thursday.

News image

ISRG Stock Falls Despite Q4 Earnings Beat & Robust Procedures

ISRG's fourth-quarter results reflect a healthy demand for procedures. Higher pricing boosts procedure sales.

News image

3 Buy-and-Hold Stocks for Long-Term Growth

When it comes to looking for "buy-and-hold forever” stocks, there are some important things to pay attention to. The most notable is the ability of these companies to benefit from trends that are likely to remain important over long periods of time.

News image

Intuitive Surgical, Inc. (ISRG) Q4 2024 Earnings Call Transcript

Intuitive Surgical, Inc. (NASDAQ:ISRG ) Q4 2024 Earnings Conference Call January 23, 2025 4:30 PM ET Company Participants Brandon Lamm - IR Gary Guthart - CEO Jamie Samath - CFO Daniel Oh - Senior Medical Officer Conference Call Participants Larry Biegelsen - Wells Fargo Robbie Marcus - JPMorgan Travis Steed - Bank of America Securities Rick Wise - Stifel David Roman - Goldman Sachs Patrick Wood - Morgan Stanley Operator Good day and thank you for standing by. Welcome to the Q4 2024 Intuitive Earnings Conference Call.

News image

Intuitive Surgical (ISRG) Reports Q4 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Intuitive Surgical (ISRG) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

News image

Markets Ramp Up to End Session; Q4 Beats for TXN, ISRG

Markets finished in robust fashion in the green today, ramping up in the final 20 minutes of trading.

News image

Intuitive Surgical, Inc. (ISRG) Q4 Earnings Surpass Estimates

Intuitive Surgical, Inc. (ISRG) came out with quarterly earnings of $2.21 per share, beating the Zacks Consensus Estimate of $1.77 per share. This compares to earnings of $1.60 per share a year ago.

News image

Intuitive Surgical beats quarterly profit estimates on strength in surgical robots business

Intuitive Surgical beat Wall Street estimates for fourth-quarter profit on Thursday, driven by strong demand for its surgical robots used in minimally invasive procedures.

News image

Intuitive Surgical's Earnings Top Estimates as It Boosts Sales of Surgical Robots

Intuitive Surgical (ISRG) reported fourth-quarter earnings that topped analysts' expectations as it boosted sales of its surgical robots.

News image

Robotic Surgery Titan Intuitive Surgical Slips On Conservative, But Expected, Guidance

Intuitive Surgical stock skidded late Thursday despite beating profit expectations following a strong sales preannouncement that sent shares on a sprint. The post Robotic Surgery Titan Intuitive Surgical Slips On Conservative, But Expected, Guidance appeared first on Investor's Business Daily.

News image

Up About 62% in a Year, Can Intuitive Surgical Stock Keep Soaring?

Shares of robotic surgery pioneer Intuitive Surgical (ISRG -0.29%) have been soaring lately. A preliminary look at sales results from the fourth quarter of 2024 suggests its business is on the right track.

News image

Intuitive Announces Fourth Quarter Earnings

SUNNYVALE, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2024.

News image

Wall Street Eyes Intuitive Surgical Q4 Earnings As Stock Hits New Heights

Intuitive Surgical, Inc. ISRG is announcing its fourth-quarter earnings on Thursday. Wall Street expects $1.79 in EPS and $2.25 billion in revenues as the company reports after market hours.

News image

Earnings Preview: What To Expect From Intuitive Surgical

Intuitive Surgical scheduled to report earnings after Thursday's close. The stock hit a record high of $614.72/share on Wednesday.

News image

My Top 5 Stocks to Buy in Early 2025

It's the start of a new year, and that makes now the perfect time to load up on stocks that could boost your portfolio in 2025 and over the long term. The healthcare space is a great place to look for these sorts of players because here you'll find all that you need to gain in both growth and security -- from young biotechs developing game-changing technologies to big pharma or medical device players selling blockbuster drugs and paying out dividends to investors.

News image

S&P 500 Misses New Closing High by 4 Points

The S&P came close to closing at a new all-time high today at 6,086, but was just a few points shy of the record close on December 6th of last year.

News image

ISRG Likely to Beat Q4 Expectations: How to Play the Stock?

Intuitive Surgical's fourth-quarter results are likely to reflect solid performance in the company's Instruments & Accessories segment. Improving margins buoy optimism.

News image

Intuitive Surgical Earnings

This section highlights Intuitive Surgical's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.

Next Earnings Date

Date: April 17, 2025
Time: After Market
Est. EPS: $1.71
Status: Unconfirmed

Last Earnings Results

Date: January 23, 2025
EPS: $2.21
Est. EPS: $1.76
Revenue: $2.41B

Earnings Call Transcripts

Transcript Quarter Year Date Estimated EPS Actual EPS
Read Transcript Q4 2024 2025-01-23 $1.76 $2.21
Read Transcript Q3 2024 2024-10-17 $1.63 $1.84
Read Transcript Q2 2024 2024-07-18 $1.54 $1.78
Read Transcript Q1 2024 2024-04-18 $1.41 $1.50
Read Transcript Q4 2023 2024-01-23 $1.48 $1.60
Read Transcript Q3 2023 2023-10-19 $1.41 $1.46
Read Transcript Q2 2023 2023-07-20 $1.33 $1.42
Read Transcript Q1 2023 2023-04-18 $1.20 $1.23

Financial Statements

Access annual & quarterly financial statements for Intuitive Surgical, including income statements, balance sheets, and cash flow statements..

Annual Income Statement

Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Revenue $8.35B $7.12B $6.22B $5.71B $4.36B
Cost of Revenue $2.72B $2.39B $2.03B $1.75B $1.50B
Gross Profit $5.63B $4.73B $4.20B $3.96B $2.86B
Gross Profit Ratio 67.46% 66.39% 67.44% 69.32% 65.65%
Research and Development Expenses $1.15B $998.80M $879.00M $671.00M $595.10M
General and Administrative Expenses $- $- $- $- $-
Selling and Marketing Expenses $- $- $- $- $-
Selling General and Administrative Expenses $2.14B $1.96B $1.74B $1.47B $1.22B
Other Expenses $- $- $- $- $-
Operating Expenses $3.29B $2.96B $2.62B $2.14B $1.81B
Cost and Expenses $-6.00B $5.36B $4.65B $3.89B $3.31B
Interest Income $324.90M $192.10M $29.70M $69.30M $157.20M
Interest Expense $- $- $29.70M $- $-
Depreciation and Amortization $324.90M $421.80M $380.40M $317.00M $282.50M
EBITDA $2.67B $2.17B $1.94B $2.13B $1.33B
EBITDA Ratio 32.01% 30.45% 25.35% 31.89% 24.09%
Operating Income $2.35B $1.77B $1.21B $1.82B $773.60M
Operating Income Ratio 28.12% 24.80% 19.47% 31.89% 17.75%
Total Other Income Expenses Net $324.90M $192.10M $29.70M $69.30M $157.20M
Income Before Tax $2.67B $1.96B $1.61B $1.89B $1.21B
Income Before Tax Ratio 32.01% 27.50% 25.82% 33.10% 27.69%
Income Tax Expense $336.30M $141.60M $262.40M $162.20M $140.20M
Net Income $2.32B $1.80B $1.32B $1.70B $1.06B
Net Income Ratio 27.81% 25.24% 21.25% 29.85% 24.33%
EPS $6.54 $5.12 $3.72 $4.79 $3.02
EPS Diluted $6.42 $5.03 $3.65 $4.66 $2.94
Weighted Average Shares Outstanding 355.20M 351.20M 355.70M 356.10M 351.00M
Weighted Average Shares Outstanding Diluted 362.00M 357.40M 362.00M 365.80M 360.90M
SEC Filing Source Source Source Source Source


Income Statement Charts

Breakdown December 31, 2024 September 30, 2024 June 30, 2024 March 31, 2024 December 31, 2023 September 30, 2023 June 30, 2023 March 31, 2023 December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020
Revenue $2.41B $2.04B $2.01B $1.89B $1.93B $1.74B $1.76B $1.70B $1.66B $1.56B $1.52B $1.49B $1.55B $1.40B $1.46B $1.29B $1.33B $1.08B $852.10M $1.10B
Cost of Revenue $771.30M $664.20M $637.20M $645.20M $650.90M $576.50M $584.00M $583.20M $544.10M $505.30M $498.80M $478.00M $489.90M $431.90M $440.30M $389.50M $433.30M $353.40M $349.20M $361.30M
Gross Profit $1.64B $1.37B $1.37B $1.25B $1.28B $1.17B $1.17B $1.11B $1.11B $1.05B $1.02B $1.01B $1.06B $971.40M $1.02B $902.60M $895.80M $724.30M $502.90M $738.20M
Gross Profit Ratio 68.04% 67.41% 68.30% 65.87% 66.24% 66.94% 66.74% 65.62% 67.12% 67.55% 67.23% 67.87% 68.41% 69.22% 69.92% 69.86% 67.40% 67.21% 59.02% 67.14%
Research and Development Expenses $294.70M $286.00M $280.10M $284.50M $260.10M $249.40M $244.40M $244.90M $244.10M $217.10M $207.30M $210.50M $183.40M $165.50M $162.30M $159.80M $149.80M $155.00M $143.20M $147.10M
General and Administrative Expenses $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $308.10M $- $- $308.10M
Selling and Marketing Expenses $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $22.10M $- $- $-
Selling General and Administrative Expenses $612.60M $510.60M $525.30M $491.50M $567.10M $452.00M $464.30M $480.50M $494.30M $436.10M $418.40M $391.10M $427.00M $363.30M $350.20M $326.00M $330.20M $298.90M $279.10M $308.10M
Other Expenses $- $- $-0.00B $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Operating Expenses $907.30M $796.60M $805.40M $776.00M $827.20M $701.40M $708.70M $725.40M $738.40M $653.20M $625.70M $601.60M $610.40M $528.80M $512.50M $485.80M $480.00M $453.90M $422.30M $455.20M
Cost and Expenses $-1.68B $1.46B $1.44B $1.42B $1.48B $1.28B $1.29B $1.31B $1.28B $1.16B $1.12B $1.08B $1.10B $960.70M $952.80M $875.30M $913.30M $807.30M $771.50M $816.50M
Interest Income $74.90M $- $87.20M $- $92.50M $45.80M $36.00M $37.90M $22.20M $3.90M $9.30M $- $- $- $- $32.00M $20.70M $- $- $-
Interest Expense $- $- $- $- $28.70M $- $- $- $22.20M $3.90M $9.30M $- $- $- $- $- $- $- $- $-
Depreciation and Amortization $74.90M $116.20M $111.80M $109.30M $114.00M $108.60M $97.30M $92.70M $112.10M $89.80M $86.00M $83.80M $83.20M $82.10M $78.90M $71.70M $79.80M $69.20M $63.80M $63.40M
EBITDA $809.80M $693.50M $679.10M $578.70M $553.80M $574.40M $560.50M $480.30M $506.80M $488.70M $483.60M $491.90M $528.50M $524.60M $586.80M $488.50M $490.20M $339.60M $144.40M $346.40M
EBITDA Ratio 33.55% 34.03% 33.79% 30.61% 29.74% 32.94% 26.38% 22.85% 22.51% 25.61% 26.12% 27.43% 29.04% 31.54% 34.92% 32.26% 31.28% 25.09% 9.46% 25.74%
Operating Income $734.90M $577.30M $567.30M $469.40M $450.20M $465.80M $365.90M $294.90M $266.30M $309.10M $311.60M $324.30M $450.40M $442.60M $511.20M $416.80M $415.80M $270.40M $80.60M $283.00M
Operating Income Ratio 30.45% 28.33% 28.23% 24.83% 23.35% 26.71% 20.84% 17.39% 16.09% 19.85% 20.47% 21.80% 29.04% 31.54% 34.92% 32.26% 31.28% 25.09% 9.46% 25.74%
Total Other Income Expenses Net $74.90M $93.70M $87.20M $69.10M $65.70M $56.20M $36.00M $34.20M $22.20M $3.90M $9.30M $-5.70M $3.80M $18.50M $15.00M $32.00M $20.70M $84.80M $26.60M $25.10M
Income Before Tax $809.80M $671.00M $654.50M $538.50M $515.90M $522.00M $499.20M $421.80M $394.70M $402.80M $406.90M $402.40M $454.20M $461.10M $526.20M $448.80M $436.50M $355.20M $107.20M $308.10M
Income Before Tax Ratio 33.55% 32.92% 32.56% 28.48% 26.75% 29.94% 28.43% 24.87% 23.85% 25.86% 26.73% 27.05% 29.29% 32.86% 35.94% 34.73% 32.84% 32.96% 12.58% 28.02%
Income Tax Expense $121.80M $100.40M $123.00M $-8.90M $-94.80M $102.20M $73.20M $61.00M $58.00M $78.10M $93.30M $33.00M $71.50M $73.90M $3.20M $13.60M $72.90M $38.40M $37.00M $-8.10M
Net Income $685.70M $565.10M $526.90M $544.90M $606.20M $415.70M $420.80M $355.30M $324.90M $324.00M $307.80M $365.60M $380.60M $380.50M $517.20M $426.30M $365.20M $313.90M $68.00M $313.50M
Net Income Ratio 28.41% 27.73% 26.22% 28.82% 31.44% 23.84% 23.96% 20.95% 19.63% 20.80% 20.22% 24.57% 24.54% 27.11% 35.33% 32.99% 27.48% 29.13% 7.98% 28.51%
EPS $1.92 $1.59 $1.48 $1.54 $1.72 $1.18 $1.20 $1.01 $0.93 $0.91 $0.86 $1.02 $1.06 $1.07 $1.45 $3.61 $1.04 $0.89 $0.19 $0.90
EPS Diluted $1.88 $1.56 $1.46 $1.51 $1.69 $1.16 $1.18 $1.00 $0.91 $0.90 $0.85 $1.00 $1.04 $1.04 $1.42 $3.51 $1.01 $0.87 $0.19 $0.87
Weighted Average Shares Outstanding 356.40M 355.80M 355.00M 353.50M 352.10M 351.70M 350.90M 350.20M 351.10M 355.30M 358.10M 358.40M 357.50M 356.80M 355.80M 353.40M 352.80M 351.90M 350.40M 349.20M
Weighted Average Shares Outstanding Diluted 363.90M 362.70M 361.00M 360.50M 358.20M 358.20M 357.30M 356.00M 357.00M 360.50M 363.90M 366.70M 367.40M 366.80M 364.80M 362.85M 363.30M 361.80M 359.10M 359.40M
SEC Filing Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source

Annual Balance Sheet

Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Cash and Cash Equivalents $2.03B $2.75B $1.58B $1.29B $1.62B
Short Term Investments $1.99B $2.47B $2.54B $2.94B $3.55B
Cash and Short Term Investments $4.01B $5.22B $6.74B $8.62B $6.87B
Net Receivables $1.36B $1.27B $1.07B $893.00M $645.50M
Inventory $1.49B $1.22B $893.20M $587.10M $601.50M
Other Current Assets $253.70M $176.70M $168.60M $133.90M $393.80M
Total Current Assets $7.11B $7.89B $8.58B $9.99B $8.12B
Property Plant Equipment Net $4.65B $3.54B $2.37B $1.88B $1.58B
Goodwill $347.50M $348.70M $348.50M $343.60M $336.70M
Intangible Assets $23.00M $39.10M $49.80M $70.50M $77.40M
Goodwill and Intangible Assets $370.50M $387.80M $348.50M $343.60M $336.70M
Long Term Investments $4.82B $2.12B $2.62B $4.42B $1.76B
Tax Assets $1.05B $910.50M $664.60M $441.40M $367.70M
Other Non-Current Assets $750.90M $597.60M $-1.61B $-3.51B $-986.60M
Total Non-Current Assets $11.63B $7.55B $4.40B $3.57B $3.05B
Other Assets $- $- $- $- $-
Total Assets $18.74B $15.44B $12.97B $13.55B $11.17B
Account Payables $193.40M $188.70M $147.00M $121.20M $81.60M
Short Term Debt $- $- $- $20.40M $-
Tax Payables $154.40M $111.40M $96.10M $54.10M $47.20M
Deferred Revenue $468.80M $446.10M $438.30M $414.00M $382.40M
Other Current Liabilities $928.70M $912.50M $781.70M $576.90M $486.10M
Total Current Liabilities $1.75B $1.66B $1.86B $1.60B $1.41B
Long Term Debt $- $64.50M $69.60M $66.60M $58.00M
Deferred Revenue Non-Current $- $45.60M $41.00M $36.80M $32.10M
Deferred Tax Liabilities Non-Current $- $- $-69.60M $- $81.00M
Other Non-Current Liabilities $468.30M $275.40M $328.70M $350.30M $354.50M
Total Non-Current Liabilities $468.30M $385.50M $439.30M $224.10M $139.00M
Other Liabilities $- $-0.00B $-439.30M $-224.10M $-139.00M
Total Liabilities $2.21B $2.04B $1.86B $1.60B $1.41B
Preferred Stock $- $- $- $- $-
Common Stock $400.00K $400.00K $400.00K $400.00K $100.00K
Retained Earnings $6.80B $4.74B $3.50B $4.76B $3.26B
Accumulated Other Comprehensive Income Loss $-51.30M $-12.20M $-162.50M $-24.20M $24.90M
Other Total Stockholders Equity $9.68B $8.58B $7.70B $7.16B $6.45B
Total Stockholders Equity $16.43B $13.31B $11.11B $11.95B $9.76B
Total Equity $16.53B $13.40B $11.18B $12.00B $9.79B
Total Liabilities and Stockholders Equity $18.74B $15.44B $12.97B $13.55B $11.17B
Minority Interest $95.90M $89.70M $70.70M $50.40M $27.60M
Total Liabilities and Total Equity $18.74B $15.44B $12.97B $13.55B $11.17B
Total Investments $6.80B $4.59B $5.16B $7.36B $5.31B
Total Debt $- $89.80M $93.80M $87.00M $79.90M
Net Debt $-2.03B $-2.66B $-1.49B $-1.20B $-1.54B


Balance Sheet Charts

Breakdown December 31, 2024 September 30, 2024 June 30, 2024 March 31, 2024 December 31, 2023 September 30, 2023 June 30, 2023 March 31, 2023 December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020
Cash and Cash Equivalents $2.03B $2.41B $3.04B $2.84B $2.75B $3.60B $3.44B $371.40M $1.58B $1.54B $1.54B $1.10B $1.29B $1.35B $1.62B $1.40B $1.62B $1.37B $2.04B $1.22B
Short Term Investments $1.99B $1.82B $1.72B $1.96B $2.47B $2.87B $2.36B $2.55B $2.54B $2.78B $2.91B $2.89B $2.94B $2.79B $2.82B $3.16B $3.55B $3.35B $2.45B $2.03B
Cash and Short Term Investments $4.01B $4.23B $4.76B $4.80B $5.22B $6.48B $7.13B $6.58B $6.74B $7.39B $8.18B $8.40B $8.62B $8.22B $7.73B $7.23B $6.87B $6.36B $6.07B $5.90B
Net Receivables $1.36B $1.29B $1.24B $1.26B $1.27B $1.10B $1.04B $1.06B $1.07B $971.10M $955.00M $1.02B $893.00M $793.60M $794.30M $733.30M $645.50M $588.60M $508.80M $527.60M
Inventory $1.49B $1.48B $1.38B $1.30B $1.22B $1.15B $1.01B $946.60M $893.20M $837.10M $724.00M $653.00M $587.10M $584.90M $569.70M $576.80M $601.50M $662.90M $645.50M $620.30M
Other Current Assets $253.70M $212.20M $270.00M $272.90M $176.70M $- $188.60M $- $168.60M $165.90M $167.50M $138.60M $133.90M $217.50M $213.40M $198.80M $267.50M $330.60M $258.80M $502.00M
Total Current Assets $7.11B $7.22B $7.65B $7.63B $7.89B $8.90B $9.04B $8.45B $8.58B $9.08B $9.74B $9.96B $9.99B $9.50B $9.00B $8.46B $8.12B $7.61B $7.59B $7.41B
Property Plant Equipment Net $4.65B $4.43B $4.12B $3.80B $3.54B $3.08B $2.83B $2.58B $2.37B $2.24B $2.11B $1.97B $1.88B $1.74B $1.65B $1.59B $1.58B $1.51B $1.45B $1.37B
Goodwill $347.50M $348.30M $348.00M $348.20M $348.70M $348.10M $348.60M $348.60M $348.50M $348.20M $349.10M $343.20M $343.60M $344.30M $344.30M $344.50M $336.70M $336.30M $336.80M $335.00M
Intangible Assets $23.00M $25.30M $28.70M $33.80M $636.70M $638.40M $693.10M $5.00M $49.80M $57.10M $66.20M $64.10M $70.50M $77.20M $84.00M $87.20M $77.40M $88.90M $101.00M $488.00M
Goodwill and Intangible Assets $370.50M $373.60M $376.70M $382.00M $985.40M $986.50M $348.60M $348.60M $348.50M $348.20M $349.10M $343.20M $343.60M $344.30M $344.30M $344.50M $336.70M $336.30M $336.80M $335.00M
Long Term Investments $4.82B $4.08B $3.14B $2.73B $2.12B $1.04B $1.33B $1.89B $2.62B $3.08B $3.74B $4.42B $4.42B $4.13B $3.30B $2.67B $1.76B $1.64B $1.59B $2.64B
Tax Assets $1.05B $997.00M $946.90M $917.80M $910.50M $701.40M $666.50M $644.70M $664.60M $587.40M $515.90M $485.40M $441.40M $411.50M $394.40M $336.60M $367.70M $360.30M $365.50M $364.70M
Other Non-Current Assets $750.90M $644.40M $412.40M $364.00M $- $- $-316.20M $-857.20M $-1.61B $-2.08B $-2.75B $-3.50B $-3.51B $-3.19B $-2.39B $-1.87B $-986.60M $-844.90M $-1.23B $-2.23B
Total Non-Current Assets $11.63B $10.53B $9.00B $8.20B $7.55B $5.81B $4.86B $4.60B $4.40B $4.18B $3.97B $3.72B $3.57B $3.44B $3.29B $3.08B $3.05B $3.00B $2.51B $2.48B
Other Assets $- $- $- $-0.00B $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Total Assets $18.74B $17.74B $16.65B $15.83B $15.44B $14.71B $13.90B $13.05B $12.97B $13.26B $13.71B $13.68B $13.55B $12.93B $12.30B $11.54B $11.17B $10.62B $10.10B $9.89B
Account Payables $193.40M $218.70M $194.40M $194.40M $188.70M $196.20M $199.70M $164.10M $147.00M $164.20M $149.70M $128.10M $121.20M $120.00M $117.90M $103.10M $81.60M $116.00M $108.90M $133.40M
Short Term Debt $- $- $- $- $- $- $- $- $- $- $- $- $20.40M $- $- $- $- $- $- $-
Tax Payables $154.40M $164.60M $85.90M $51.80M $111.40M $342.80M $230.20M $125.40M $96.10M $71.20M $40.80M $113.30M $54.10M $65.90M $58.80M $50.70M $47.20M $35.30M $37.70M $34.60M
Deferred Revenue $468.80M $426.00M $433.90M $437.50M $446.10M $394.80M $450.60M $462.50M $438.30M $395.60M $413.70M $424.40M $414.00M $383.50M $392.00M $389.20M $382.40M $358.10M $371.50M $366.20M
Other Current Liabilities $928.70M $867.50M $773.30M $691.40M $912.50M $742.60M $703.30M $600.10M $781.70M $639.10M $608.20M $484.80M $576.90M $492.90M $467.90M $392.70M $486.10M $415.60M $435.10M $440.50M
Total Current Liabilities $1.75B $1.68B $1.49B $1.38B $1.66B $1.68B $1.94B $1.76B $1.86B $1.69B $1.62B $1.52B $1.60B $1.48B $1.42B $1.35B $1.41B $1.33B $1.34B $1.36B
Long Term Debt $- $- $- $- $64.50M $- $- $- $69.60M $- $- $- $66.60M $- $- $- $58.00M $- $- $-
Deferred Revenue Non-Current $54.10M $59.60M $43.50M $50.20M $45.60M $42.50M $45.40M $44.70M $41.00M $36.70M $37.40M $38.40M $36.80M $35.00M $32.00M $31.10M $32.10M $30.30M $28.40M $28.80M
Deferred Tax Liabilities Non-Current $- $- $- $- $82.10M $- $- $- $-69.60M $- $- $- $229.60M $- $- $- $-58.00M $- $- $-
Other Non-Current Liabilities $414.20M $329.50M $322.40M $356.30M $275.40M $370.30M $359.80M $406.90M $328.70M $416.70M $410.40M $370.90M $350.30M $412.80M $380.90M $414.50M $354.50M $405.80M $384.00M $385.90M
Total Non-Current Liabilities $468.30M $389.10M $365.90M $406.50M $385.50M $412.80M $405.20M $462.50M $439.30M $453.40M $447.80M $409.30M $453.70M $447.80M $412.90M $445.60M $444.60M $436.10M $412.40M $414.70M
Other Liabilities $- $- $- $- $- $- $-405.20M $-462.50M $-439.30M $-453.40M $-447.80M $-409.30M $-453.70M $-447.80M $-412.90M $-445.60M $-444.60M $-436.10M $-412.40M $-414.70M
Total Liabilities $2.21B $2.07B $1.85B $1.78B $2.04B $2.09B $1.94B $1.76B $1.86B $1.69B $1.62B $1.52B $1.60B $1.48B $1.42B $1.35B $1.41B $1.33B $1.34B $1.36B
Preferred Stock $- $- $- $- $- $- $80.60M $- $- $- $- $- $50.40M $48.60M $42.00M $36.70M $27.60M $28.90M $25.90M $23.80M
Common Stock $400.00K $400.00K $400.00K $400.00K $400.00K $400.00K $400.00K $400.00K $400.00K $400.00K $400.00K $400.00K $400.00K $400.00K $100.00K $100.00K $100.00K $100.00K $100.00K $100.00K
Retained Earnings $6.80B $6.13B $5.58B $5.07B $4.74B $4.21B $3.81B $3.40B $3.50B $4.02B $4.68B $4.86B $4.76B $4.39B $4.02B $3.51B $3.26B $2.94B $2.63B $2.57B
Accumulated Other Comprehensive Income Loss $-51.30M $12.90M $-23.50M $-8.70M $-12.20M $-56.50M $-79.80M $-108.50M $-162.50M $-187.60M $-144.20M $-110.70M $-24.20M $5.30M $10.30M $11.40M $24.90M $16.20M $22.30M $8.90M
Other Total Stockholders Equity $9.68B $9.44B $9.15B $8.90B $8.58B $8.39B $8.15B $7.93B $7.70B $7.68B $7.48B $7.35B $7.16B $7.02B $6.80B $6.63B $6.45B $6.30B $6.09B $5.93B
Total Stockholders Equity $16.43B $15.58B $14.71B $13.96B $13.31B $12.54B $11.96B $11.29B $11.11B $11.57B $12.08B $12.16B $11.95B $11.46B $10.88B $10.19B $9.76B $9.29B $8.77B $8.53B
Total Equity $16.53B $15.68B $14.80B $14.05B $13.40B $12.62B $12.04B $11.37B $11.18B $11.63B $12.14B $12.21B $12.00B $11.51B $10.92B $10.23B $9.79B $9.32B $8.79B $8.55B
Total Liabilities and Stockholders Equity $18.74B $17.74B $16.65B $15.83B $15.44B $14.71B $13.90B $13.05B $12.97B $13.26B $13.71B $13.68B $13.55B $12.93B $12.30B $11.54B $11.17B $10.62B $10.10B $9.89B
Minority Interest $95.90M $94.20M $88.20M $83.80M $89.70M $84.50M $80.60M $76.50M $70.70M $58.60M $59.40M $54.60M $50.40M $48.60M $42.00M $36.70M $27.60M $28.90M $25.90M $23.80M
Total Liabilities and Total Equity $18.74B $17.74B $16.65B $15.83B $15.44B $14.71B $13.90B $13.05B $12.97B $13.26B $13.71B $13.68B $13.55B $12.93B $12.30B $11.54B $11.17B $10.62B $10.10B $9.89B
Total Investments $6.80B $5.90B $4.86B $4.69B $4.59B $3.92B $3.70B $4.44B $5.16B $5.86B $6.65B $7.31B $7.36B $6.92B $6.12B $5.83B $5.31B $4.99B $4.04B $4.67B
Total Debt $- $- $- $- $89.80M $- $- $- $93.80M $- $- $- $87.00M $- $- $- $58.00M $275.70M $- $-
Net Debt $-2.03B $-2.41B $-3.04B $-2.84B $-2.66B $-3.60B $-3.44B $-371.40M $-1.49B $-1.54B $-1.54B $-1.10B $-1.20B $-1.35B $-1.62B $-1.40B $-1.56B $-1.09B $-2.04B $-1.22B

Annual Cash Flow

Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Net Income $2.34B $1.82B $1.34B $1.73B $1.07B
Depreciation and Amortization $-26.60M $435.20M $365.80M $310.20M $276.20M
Deferred Income Tax $-135.30M $-280.80M $-185.30M $-62.60M $57.60M
Stock Based Compensation $676.80M $598.20M $513.20M $449.20M $395.40M
Change in Working Capital $- $-777.60M $-619.10M $-368.10M $-273.20M
Accounts Receivables $-95.90M $-186.30M $-159.30M $-142.30M $5.70M
Inventory $-830.00M $-712.50M $-546.60M $-256.00M $-170.10M
Accounts Payables $-400.00K $41.70M $21.30M $36.00M $-32.30M
Other Working Capital $- $79.50M $65.50M $-5.80M $-76.50M
Other Non Cash Items $-437.40M $21.50M $71.80M $32.60M $-38.00M
Net Cash Provided by Operating Activities $2.42B $1.81B $1.49B $2.09B $1.48B
Investments in Property Plant and Equipment $-1.11B $-1.06B $-532.40M $-353.50M $-341.50M
Acquisitions Net $- $-8.90M $-12.80M $-8.70M $-37.70M
Purchases of Investments $-5.14B $-2.21B $-1.40B $-6.45B $-4.29B
Sales Maturities of Investments $2.98B $2.92B $3.32B $4.35B $3.73B
Other Investing Activities $-1.00M $- $1.92B $-2.10B $-561.40M
Net Cash Used for Investing Activities $-3.27B $-360.10M $1.37B $-2.46B $-940.60M
Debt Repayment $- $- $- $- $-
Common Stock Issued $429.40M $- $233.80M $276.50M $308.80M
Common Stock Repurchased $- $-416.30M $-2.61B $-211.60M $-134.30M
Dividends Paid $-8.00M $- $- $- $-
Other Financing Activities $158.90M $128.70M $35.10M $43.00M $48.60M
Net Cash Used Provided by Financing Activities $150.90M $-287.60M $-2.57B $43.00M $-85.70M
Effect of Forex Changes on Cash $-800.00K $3.30M $5.40M $-3.40M $-2.60M
Net Change in Cash $-707.70M $1.17B $294.70M $-332.50M $455.90M
Cash at End of Period $2.06B $2.77B $1.60B $1.31B $1.64B
Cash at Beginning of Period $2.77B $1.60B $1.31B $1.64B $1.18B
Operating Cash Flow $2.42B $1.81B $1.49B $2.09B $1.48B
Capital Expenditure $-1.11B $-1.06B $-532.40M $-353.50M $-341.50M
Free Cash Flow $1.30B $749.60M $958.40M $1.74B $1.14B

Cash Flow Charts

Breakdown December 31, 2024 September 30, 2024 June 30, 2024 March 31, 2024 December 31, 2023 September 30, 2023 June 30, 2023 March 31, 2023 December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020
Net Income $688.00M $570.60M $526.90M $544.90M $610.70M $419.80M $426.00M $360.80M $336.70M $324.70M $313.60M $369.40M $382.70M $387.20M $523.00M $435.20M $363.60M $316.80M $70.20M $316.20M
Depreciation and Amortization $124.70M $116.20M $111.80M $109.30M $123.20M $108.60M $97.30M $92.70M $106.20M $89.80M $86.00M $83.80M $80.90M $82.00M $75.60M $71.70M $79.80M $69.20M $63.80M $63.40M
Deferred Income Tax $-30.80M $-64.70M $-32.60M $-7.20M $-219.80M $-43.30M $-27.00M $9.30M $-83.30M $-61.90M $-25.70M $-14.40M $-22.00M $-16.60M $-68.70M $44.70M $-14.30M $19.40M $-12.00M $64.50M
Stock Based Compensation $177.00M $172.90M $173.60M $153.30M $150.40M $156.10M $146.50M $139.80M $127.60M $138.10M $126.70M $120.80M $117.80M $120.10M $108.10M $103.20M $103.10M $105.80M $95.90M $90.60M
Change in Working Capital $-140.80M $-85.60M $-152.90M $-540.00M $-439.20M $-100.80M $5.90M $-243.50M $-60.80M $-124.20M $-68.70M $-365.40M $-10.90M $-79.00M $-108.70M $-169.50M $81.50M $-179.00M $10.50M $-186.20M
Accounts Receivables $-74.10M $-42.80M $18.80M $2.20M $-166.60M $-59.00M $22.40M $16.90M $-92.10M $-11.20M $67.40M $-123.40M $-87.60M $4.90M $-45.30M $-14.30M $-51.50M $-79.70M $18.70M $118.20M
Inventory $-179.10M $-261.50M $-209.80M $-179.60M $-184.30M $-239.60M $-161.50M $-127.10M $-127.50M $-173.60M $-125.40M $-120.10M $-66.80M $-96.80M $-51.20M $-41.20M $6.90M $-56.90M $-54.90M $-65.20M
Accounts Payables $-21.60M $22.80M $5.90M $-7.50M $14.00M $-8.80M $19.60M $16.90M $-5.00M $13.90M $14.30M $-1.90M $200.00K $-2.40M $14.50M $23.70M $-28.40M $-300.00K $-25.50M $21.90M
Other Working Capital $134.00M $195.90M $32.20M $-355.10M $-102.30M $206.60M $125.40M $-150.20M $163.80M $46.70M $-25.00M $-120.00M $143.30M $15.30M $-26.70M $-137.70M $154.50M $-42.10M $72.20M $-261.10M
Other Non Cash Items $4.50M $-2.90M $576.00M $335.30M $3.00M $8.00M $17.00M $12.30M $11.50M $16.70M $14.80M $28.80M $19.20M $7.70M $13.40M $-7.70M $13.80M $-57.60M $1.50M $4.30M
Net Cash Provided by Operating Activities $822.60M $706.50M $620.50M $38.80M $228.30M $548.40M $665.70M $371.40M $437.90M $383.20M $446.70M $223.00M $567.70M $501.40M $542.70M $477.60M $627.50M $274.60M $229.90M $352.80M
Investments in Property Plant and Equipment $-312.00M $-247.90M $-309.40M $-241.90M $-435.50M $-256.30M $-178.30M $-194.10M $-137.70M $-169.10M $-130.50M $-95.10M $-150.90M $-68.30M $-75.70M $-58.60M $-61.90M $-64.40M $-110.00M $-105.20M
Acquisitions Net $-1.00M $113.40M $- $-113.40M $-1.80M $200.00K $-7.30M $-767.20M $-1.20M $200.00K $-11.80M $-1.50M $-14.00M $- $- $-8.70M $-105.20M $- $- $-37.70M
Purchases of Investments $-1.43B $-1.92B $-883.50M $-905.90M $-1.39B $-806.20M $-10.50M $-3.50M $-5.90M $-17.40M $-188.90M $-1.19B $-1.24B $-1.71B $-1.67B $-1.83B $-1.27B $-1.60B $-736.80M $-690.00M
Sales Maturities of Investments $478.80M $755.10M $725.80M $1.02B $780.30M $615.70M $753.70M $770.70M $719.60M $730.80M $797.40M $1.07B $748.20M $935.50M $1.37B $1.30B $997.30M $634.90M $1.38B $715.80M
Other Investing Activities $- $-113.40M $-157.70M $113.40M $-606.90M $-190.50M $743.20M $767.20M $713.70M $713.40M $608.50M $-119.60M $-490.10M $-770.50M $-309.00M $-529.70M $105.20M $-961.50M $646.70M $25.80M
Net Cash Used for Investing Activities $-1.26B $-1.41B $-467.10M $-128.50M $-1.04B $-446.60M $557.60M $573.10M $574.80M $544.50M $466.20M $-214.70M $-641.00M $-838.80M $-384.70M $-597.00M $-334.30M $-1.03B $536.70M $-117.10M
Debt Repayment $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Common Stock Issued $- $115.60M $71.50M $180.40M $44.10M $77.40M $74.60M $100.20M $- $- $- $80.00M $276.50M $91.10M $69.70M $84.00M $- $- $- $91.30M
Common Stock Repurchased $- $240.10M $-13.50M $-226.60M $-66.30M $-14.80M $-10.90M $-350.00M $-1.00B $-1.00B $-500.10M $-106.50M $-10.40M $-13.30M $-9.60M $- $-34.30M $-10.20M $-6.20M $-100.00M
Dividends Paid $- $-8.00M $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Other Financing Activities $49.40M $106.20M $50.00M $-46.70M $78.90M $61.80M $63.30M $-31.20M $82.50M $155.20M $18.00M $-93.40M $18.60M $68.30M $58.30M $-186.20M $35.40M $85.20M $47.60M $-78.70M
Net Cash Used Provided by Financing Activities $49.40M $98.20M $50.00M $179.90M $-31.50M $61.80M $63.30M $-381.20M $-963.50M $-926.80M $-482.10M $-199.90M $18.60M $68.30M $58.30M $-102.20M $-39.80M $85.20M $47.60M $-178.70M
Effect of Forex Changes on Cash $8.30M $-12.20M $-3.70M $6.80M $-5.40M $1.70M $5.20M $1.80M $-2.50M $1.90M $2.20M $3.80M $-1.10M $300.00K $-3.40M $800.00K $-600.00K $-400.00K $-800.00K $-800.00K
Net Change in Cash $-383.90M $-590.40M $197.20M $89.40M $-852.80M $165.30M $1.29B $565.10M $46.70M $2.80M $433.00M $-187.80M $-55.80M $-268.80M $212.90M $-220.80M $252.80M $-666.50M $813.40M $56.20M
Cash at End of Period $2.06B $2.45B $3.04B $2.84B $2.77B $3.62B $3.46B $2.17B $1.60B $1.55B $1.55B $1.12B $1.31B $1.36B $1.63B $1.42B $1.64B $1.39B $2.05B $1.24B
Cash at Beginning of Period $2.45B $3.04B $2.84B $2.75B $3.62B $3.46B $2.17B $1.60B $1.55B $1.55B $1.12B $1.31B $1.36B $1.63B $1.42B $1.64B $1.39B $2.05B $1.24B $1.18B
Operating Cash Flow $822.60M $706.50M $620.50M $38.80M $228.30M $548.40M $665.70M $371.40M $437.90M $383.20M $446.70M $223.00M $567.70M $501.40M $542.70M $477.60M $627.50M $274.60M $229.90M $352.80M
Capital Expenditure $-312.00M $-247.90M $-309.40M $-241.90M $-435.50M $-256.30M $-178.30M $-194.10M $-137.70M $-169.10M $-130.50M $-95.10M $-150.90M $-68.30M $-75.70M $-58.60M $-61.90M $-64.40M $-110.00M $-105.20M
Free Cash Flow $510.60M $458.60M $311.10M $-203.10M $-207.20M $292.10M $487.40M $177.30M $300.20M $214.10M $316.20M $127.90M $416.80M $433.10M $467.00M $419.00M $565.60M $210.20M $119.90M $247.60M


Intuitive Surgical Stock Forecast

Analyst ratings, price targets, and earnings estimates for ISRG.

ISRG Analyst Ratings

Strong Buy

Buy
15
Hold
4
Sell
0

Based on 19 analysts in the past 3 months

ISRG Stock 12 Month Forecast

$645.00

▲ (9.54% Upside)
Highest Price Target
$ (0.0%)
Average Price Target
$645.00 (9.5%)
Lowest Price Target
$ (0.0%)

Based on 2 analysts in the last 3 months

Recent Price Targets
Recommendation Trends
Analyst Estimates
Revenue Estimates
High $9.70B
Average $9.59B
Low $9.46B
21 analysts
Net Income Estimates
High $2.99B
Average $2.91B
Low $2.83B
21 analysts
EPS Estimates
High $8.25
Average $8.07
Low $7.81
17 analysts
Revenue Estimates
High $11.47B
Average $11.10B
Low $10.67B
23 analysts
Net Income Estimates
High $3.66B
Average $3.41B
Low $3.16B
23 analysts
EPS Estimates
High $10.12
Average $9.48
Low $8.74
16 analysts
Revenue Estimates
High $12.85B
Average $12.82B
Low $12.79B
17 analysts
Net Income Estimates
High $4.04B
Average $4.00B
Low $3.95B
17 analysts
EPS Estimates
High $11.17
Average $11.05
Low $10.92
2 analysts
Revenue Estimates
High $14.69B
Average $14.02B
Low $13.57B
8 analysts
Net Income Estimates
High $4.61B
Average $4.34B
Low $4.16B
8 analysts
EPS Estimates
High $12.75
Average $12.00
Low $11.50
1 analysts
Revenue Estimates
High $16.55B
Average $15.79B
Low $15.29B
13 analysts
Net Income Estimates
High $5.39B
Average $5.07B
Low $4.86B
13 analysts
EPS Estimates
High $14.88
Average $14.01
Low $13.42
1 analysts
Latest Price Target Updates
Date Analyst Firm Price Target Price When Posted Upside
Dec 18, 2024 Richard Newitter Truist Financial $640.00 $526.47 21.6%
Dec 02, 2024 Patrick Wood Morgan Stanley $650.00 $541.93 19.9%
Oct 18, 2024 David Roman Goldman Sachs $604.00 $517.97 16.6%
Oct 18, 2024 Shagun Singh RBC Capital $555.00 $473.73 17.2%
Oct 18, 2024 Adam Maeder Piper Sandler $538.00 $473.73 13.6%
Oct 18, 2024 Anthony Petrone Mizuho Securities $550.00 $473.73 16.1%
Oct 18, 2024 Rick Wise Stifel Nicolaus $525.00 $473.73 10.8%
Oct 18, 2024 Richard Newitter Truist Financial $570.00 $473.73 20.3%
Oct 18, 2024 Vijay Kumar Evercore ISI $490.00 $473.73 3.4%
Oct 18, 2024 Ryan Zimmerman BTIG $535.00 $473.73 12.9%

Intuitive Surgical Dividends

Explore Intuitive Surgical's dividend history, including dividend yield, payout ratio, and historical payments.

Intuitive Surgical does not currently pay a dividend.

Peers: Medical - Instruments & Supplies

This section provides companies within the same sector, on the same exchange, and of similar market capitalization, allowing comparisons of key financial indicators among peers.

Company Market Cap Price EPS P/E Ratio P/B Ratio
RGEN Logo
Repligen Corporation
RGEN
$8.96B $160.00 $0.64 $281.45 $5.08
RMD Logo
ResMed Inc.
RMD
$34.95B $237.96 $6.94 $26.92 $5.65
MMSI Logo
Merit Medical Systems, Inc.
MMSI
$6.34B $108.85 $1.64 $46.34 $3.64
ICUI Logo
ICU Medical, Inc.
ICUI
$3.87B $158.13 $-1.23 $-81.03 $1.13
BNGO Logo
Bionano Genomics, Inc.
BNGO
$13.11M $5.63 $-6.81 $-16.66 $40.27
LUCY Logo
Innovative Eyewear, Inc.
LUCY
$11.97M $4.90 $-12.67 $-0.67 $0.80
STXS Logo
Stereotaxis, Inc.
STXS
$211.74M $2.50 $-0.26 $-6.82 $6.44
NXGL Logo
NEXGEL, Inc.
NXGL
$23.22M $3.42 $-0.56 $-3.83 $2.57
EMBC Logo
Embecta Corp.
EMBC
$1.03B $17.69 $0.00 $0.00 $0.00
BAX Logo
Baxter International Inc.
BAX
$15.68B $30.71 $5.25 $7.37 $2.33
WST Logo
West Pharmaceutical Services, Inc.
WST
$23.88B $329.72 $7.99 $44.09 $9.08
COO Logo
The Cooper Companies, Inc.
COO
$18.94B $94.90 $1.97 $53.07 $2.58
TFX Logo
Teleflex Incorporated
TFX
$8.00B $172.27 $7.58 $32.87 $2.64
BDX Logo
Becton, Dickinson and Company
BDX
$66.40B $228.97 $5.88 $40.97 $2.70
HOLX Logo
Hologic, Inc.
HOLX
$14.66B $64.94 $3.35 $24.13 $3.71
Ownership